Director, Corporate Strategy & Development at Masimo
Yiwen Li is a healthcare & emerging tech investor and global commercialization strategist. She is currently the Director for Strategy and Business Development at Masimo (NASDAQ: MASI), a global medical technology company that develops innovative patient monitoring technologies and medical devices. Previously, she was Director of Global Strategy at NantHealth (NASDAQ: NH), where she led the international expansion of its connectivity platform and precision medicine solutions.
Yiwen is a veteran with 12+ years’ experience in investing, including equity research and wealth management at Capital Group, and direct venture investing at NantWorks. Prior to Capital Group, Yiwen worked at the United Nations headquarter in Vienna with United Nations Industrial Development Organization.
Yiwen is a Board of Director at Give2Asia, a Board of Director of Asia Society, an executive committee member of C-Sweet, also a representative for Committee of 100 ‘s Next Generation Leader initiative.
Yiwen received her master’s degree in economics from the London School of Economics and a second master’s degree in Global Studies from University of Vienna. She is fluent in English, Mandarin, and German. She is the author of one of the best sellers in China “ Make the World Your Playground”.
Join the AI LA Community with The Gao Research Group at the California Institute of Technology as we discuss how a highly interdisciplinary research team is developing versatile bioelectronic devices for fundamental and applied biomedical studies for system-level applications toward personalized and precision medicine.
until Connect Week 2021